Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis

被引：0
|
作者：
Lauren Shaiova
Jeanne Lapin
Lorraine S. Manco
Daniel Shasha
Kenneth Hu
Louis Harrison
Russell K. Portenoy
机构：
[1] Beth Israel Medical Center,Department of Pain Medicine and Palliative Care
[2] Beth Israel Medical Center,Department of Radiation Oncology
来源：
Supportive Care in Cancer | 2004年 / 12卷
关键词：
Oral transmucosal fentanyl citrate; Mucositis; Pain; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：268 / 273
页数：5
相关论文
共 50 条
  • [1] Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis
    Shaiova, L
    Lapin, J
    Manco, LS
    Shasha, D
    Hu, K
    Harrison, L
    Portenoy, RK
    SUPPORTIVE CARE IN CANCER, 2004, 12 (04) : 268 - 273
  • [2] Oral transmucosal fentanyl citrate -: OTFC (ACTIQ™) #103
    Gordon, Debra
    Schroeder, Mark
    JOURNAL OF PALLIATIVE MEDICINE, 2008, 11 (04) : 633 - 634
  • [3] ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF POSTOPERATIVE PAIN
    ASHBURN, MA
    LIND, GH
    GILLIE, MH
    DEBOER, AJF
    PACE, NL
    STANLEY, TH
    ANESTHESIA AND ANALGESIA, 1993, 76 (02): : 377 - 381
  • [4] Use of oral transmucosal fentanyl citrate (OTFC) in TRUS prostate biopsy patients
    Sharma, H.
    Maheshkumar, P.
    BJU INTERNATIONAL, 2009, 103 : 12 - 12
  • [5] Influence of CYP3A activity on the effects of oral transmucosal fentanyl citrate (OTFC).
    Kharasch, ED
    Hoffer, CJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P26 - P26
  • [6] Evidence-based oral transmucosal fentanyl citrate (OTFC®) dosing guidelines
    Aronoff, GM
    Brennan, MJ
    Pritchard, DD
    Ginsberg, B
    PAIN MEDICINE, 2005, 6 (04) : 305 - 314
  • [7] A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients
    Scandurra, G.
    Ferraro, G.
    Franchina, T.
    Chiofalo, G.
    Zanghi, M.
    Festa, V
    Pastura, G.
    Adamo, V
    ANNALS OF ONCOLOGY, 2006, 17 : XI70 - XI70
  • [8] Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain:: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC®, ACTIQ®)
    Taylor, Donald R.
    Webster, Lynn R.
    Chun, Steven Y.
    Reinking, Jeffrey
    Stegman, Mary
    Shoemaker, Steven
    Fortner, Barry
    PAIN MEDICINE, 2007, 8 (03) : 281 - 288
  • [9] Oral transmucosal fentanyl citrate (OTFC) compared with IV morphine for acute pain in patients following abdominal surgery
    Sevarino, FB
    Ginsberg, B
    Lichtor, JL
    Joshi, GP
    Nordbrock, E
    Busch, MA
    ANESTHESIA AND ANALGESIA, 1997, 84 : S330 - S330
  • [10] PROTOCOL IN PATIENTS (PTS) TREATED FOR PAIN IN BONE METASTASIS (MTS): IS THERE A ROLE FOR ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC)?
    Daidone, A.
    Moscadini, L.
    Grillo, A.
    Mangiapane, M.
    Valentina, V. Gruppuso
    Guerrieri, P.
    Montemaggi, P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S378 - S378
12345